1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HCFC1 CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA DNMT3A CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA ZNF397 CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA TPD52L2 CTRPv2 pan-cancer AAC -0.21 2e-09
mRNA MCFD2 CTRPv2 pan-cancer AAC -0.21 2e-09
mRNA FAM209A CTRPv2 pan-cancer AAC -0.2 2e-09
mRNA RSBN1 CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA CASP8AP2 CTRPv2 pan-cancer AAC 0.2 2e-09
mRNA KIF1A CTRPv2 pan-cancer AAC 0.21 3e-09
mRNA C2CD4C CTRPv2 pan-cancer AAC 0.19 3e-09
Download CSV